{"id":953261,"date":"2026-04-21T08:06:27","date_gmt":"2026-04-21T12:06:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/"},"modified":"2026-04-21T08:06:27","modified_gmt":"2026-04-21T12:06:27","slug":"krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/","title":{"rendered":"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026"},"content":{"rendered":"
\n

PITTSBURGH, April 21, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc.<\/u><\/a> (the \u201cCompany\u201d) (NASDAQ: KRYS) announced today that it will report its first quarter 2026 financial results on Monday, May 4, 2026, prior to the open of U.S. markets.<\/p>\n

The Company\u2019s management will also host a conference call and webcast at\u00a08:30 am ET on\u00a0Monday, May 4, 2026, to discuss the financial results and provide a business update.<\/p>\n

Investors and the general public can access the live webcast at: https:\/\/www.webcaster5.com\/Webcast\/Page\/3018\/53916<\/u><\/a>.<\/p>\n

For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com<\/a>.<\/p>\n

\n About Krystal Biotech, Inc.<\/strong>
\n
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK\u00ae<\/sup>, the Company\u2019s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http:\/\/www.krystalbio.com<\/a>, and follow @KrystalBiotech on LinkedIn<\/u><\/a> and X<\/a> (formerly Twitter).<\/p>\n

\n CONTACT<\/strong>
\n
\n Investors and Media: <\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
St\u00e9phane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com<\/a>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PITTSBURGH, April 21, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the \u201cCompany\u201d) (NASDAQ: KRYS) announced today that it will report its first quarter 2026 financial results on Monday, May 4, 2026, prior to the open of U.S. markets. The Company\u2019s management will also host a conference call and webcast at\u00a08:30 am ET on\u00a0Monday, May 4, 2026, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https:\/\/www.webcaster5.com\/Webcast\/Page\/3018\/53916. For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com. About Krystal Biotech, Inc. Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, … <\/p>\n

Continue reading “Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-953261","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKrystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PITTSBURGH, April 21, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the \u201cCompany\u201d) (NASDAQ: KRYS) announced today that it will report its first quarter 2026 financial results on Monday, May 4, 2026, prior to the open of U.S. markets. The Company\u2019s management will also host a conference call and webcast at\u00a08:30 am ET on\u00a0Monday, May 4, 2026, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https:\/\/www.webcaster5.com\/Webcast\/Page\/3018\/53916. For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com. About Krystal Biotech, Inc. Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, … Continue reading "Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-21T12:06:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026\",\"datePublished\":\"2026-04-21T12:06:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/\"},\"wordCount\":240,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/\",\"name\":\"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=\",\"datePublished\":\"2026-04-21T12:06:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/","og_locale":"en_US","og_type":"article","og_title":"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - Market Newsdesk","og_description":"PITTSBURGH, April 21, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the \u201cCompany\u201d) (NASDAQ: KRYS) announced today that it will report its first quarter 2026 financial results on Monday, May 4, 2026, prior to the open of U.S. markets. The Company\u2019s management will also host a conference call and webcast at\u00a08:30 am ET on\u00a0Monday, May 4, 2026, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: https:\/\/www.webcaster5.com\/Webcast\/Page\/3018\/53916. For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company\u2019s website at\u00a0www.krystalbio.com. About Krystal Biotech, Inc. Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, … Continue reading \"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-21T12:06:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026","datePublished":"2026-04-21T12:06:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/"},"wordCount":240,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/","name":"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=","datePublished":"2026-04-21T12:06:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MzA5MiM3NTQ0NjU1IzIwOTE5Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-to-report-first-quarter-2026-financial-results-on-may-4-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/953261","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=953261"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/953261\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=953261"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=953261"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=953261"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}